Last reviewed · How we verify

Apixaban Oral Tablet [Eliquis]

Hadassah Medical Organization · Phase 3 active Small molecule Quality 0/100

Apixaban Oral Tablet [Eliquis] is a Small molecule drug developed by Hadassah Medical Organization. It is currently in Phase 3 development. Also known as: Eliquis.

At a glance

Generic nameApixaban Oral Tablet [Eliquis]
Also known asEliquis
SponsorHadassah Medical Organization
ModalitySmall molecule
PhasePhase 3

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Apixaban Oral Tablet [Eliquis]

What is Apixaban Oral Tablet [Eliquis]?

Apixaban Oral Tablet [Eliquis] is a Small molecule drug developed by Hadassah Medical Organization.

Who makes Apixaban Oral Tablet [Eliquis]?

Apixaban Oral Tablet [Eliquis] is developed by Hadassah Medical Organization (see full Hadassah Medical Organization pipeline at /company/hadassah-medical-organization).

Is Apixaban Oral Tablet [Eliquis] also known as anything else?

Apixaban Oral Tablet [Eliquis] is also known as Eliquis.

What development phase is Apixaban Oral Tablet [Eliquis] in?

Apixaban Oral Tablet [Eliquis] is in Phase 3.

Related